Company News
July 10 Further Tournistrip trial data released
Further trial data has been released relating to a trial during the latter part of last year. Click here for the results!
Tournistrip, the only tourniquet to have been clinically trialed
78% of phlebotomists actually preferred Tournistrip to their current tourniquet
A high proportion of conventional tourniquets are contaminated with blood and bacterial pathogens
The average reusable Tourniquet is owned for 1.86 years
Tournistrip's unique design and construction mean that it is truly single use